ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
1-Year Return
169.78%
This Quarter Return
-1%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$128M
AUM Growth
-$34M
(-21%)
Cap. Flow
-$25.1M
Cap. Flow
% of AUM
-19.51%
Top 10 Holdings %
Top 10 Hldgs %
71.04%
Holding
41
New
5
Increased
7
Reduced
12
Closed
6
Top Buys
| 1 |
Apellis Pharmaceuticals
APLS
|
$4.82M |
| 2 |
4D Molecular Therapeutics
FDMT
|
$1.8M |
| 3 |
argenx
ARGX
|
$1.67M |
| 4 |
Alkermes
ALKS
|
$893K |
| 5 |
Kura Oncology
KURA
|
$780K |
Top Sells
| 1 |
Viridian Therapeutics
VRDN
|
$5.81M |
| 2 |
Sarepta Therapeutics
SRPT
|
$4.79M |
| 3 |
BioAtla
BCAB
|
$4.13M |
| 4 |
Mersana Therapeutics
MRSN
|
$3.66M |
| 5 |
Keros Therapeutics
KROS
|
$3.26M |
Sector Composition
| 1 | Healthcare | 99.99% |
